Nuclear factor-κB:: its role in health and disease

被引:810
作者
Kumar, A [1 ]
Takada, Y
Boriek, AM
Aggarwal, BB
机构
[1] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
[2] Univ Texas, Dept Bioimmunotherapy, MD Anderson Canc Ctr, Cytokine Res Lab, Houston, TX 77030 USA
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2004年 / 82卷 / 07期
关键词
nuclear factor-kappa B; tumorigenesis; inflammation; immunity; therapy;
D O I
10.1007/s00109-004-0555-y
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Nuclear factor-kappaB (NF-kappaB) is a major transcription factor that plays an essential role in several aspects of human health including the development of innate and adaptive immunity. The dysregulation of NF-kappaB is associated with many disease states such as AIDS, atherosclerosis, asthma, arthritis, cancer, diabetes, inflammatory bowel disease, muscular dystrophy, stroke, and viral infections. Recent evidence also suggests that the dysfunction of NF-kappaB is a major mediator of some human genetic disorders. Appropriate regulation and control of NF-kappaB activity, which can be achieved by gene modification or pharmacological strategies, would provide a potential approach for the management of NF-kappaB related human diseases. This review summarizes the current knowledge of the physiological and pathophysiological functions of NF-kappaB and its possible role as a target of therapeutic intervention.
引用
收藏
页码:434 / 448
页数:15
相关论文
共 193 条
[51]   Tyrosine phosphorylation of IκBα activates NFκB through a redox-regulated and c-Src-dependent mechanism following hypoxia/reoxygenation [J].
Fan, CG ;
Li, Q ;
Ross, D ;
Engelhardt, JF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) :2072-2080
[52]  
Ferreira V, 1999, J IMMUNOL, V162, P6442
[53]  
FRACCHIOLLA NS, 1993, ONCOGENE, V8, P2839
[54]   Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure [J].
Frantz, S ;
Fraccarollo, D ;
Wagner, H ;
Behr, TM ;
Jung, P ;
Angermann, CE ;
Ertl, G ;
Bauersachs, J .
CARDIOVASCULAR RESEARCH, 2003, 57 (03) :749-756
[55]   Requirement for NF-κB in osteoclast and B-cell development [J].
Franzoso, G ;
Carlson, L ;
Xing, LP ;
Poljak, L ;
Shores, EW ;
Brown, KD ;
Leonardi, A ;
Tran, T ;
Boyce, BF ;
Siebenlist, U .
GENES & DEVELOPMENT, 1997, 11 (24) :3482-3496
[56]   The regulation and roles of Rel/NF-κB transcription factors during lymphocyte activation [J].
Gerondakis, S ;
Grumont, R ;
Rourke, I ;
Grossmann, M .
CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (03) :353-359
[57]   NF-κB and rel proteins:: Evolutionarily conserved mediators of immune responses [J].
Ghosh, S ;
May, MJ ;
Kopp, EB .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :225-260
[58]  
Gilmore TD, 1996, ONCOGENE, V13, P1367
[59]  
Gilston Vanessa, 1997, Biochemical Society Transactions, V25, p518S
[60]   Constitutive activation of NF-κB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells -: Autocrine role of tumor necrosis factor and reactive oxygen intermediates [J].
Giri, DK ;
Aggarwal, BB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (22) :14008-14014